Takara BioFRA:TF2 71 Days Inventory is 192.94 as of Mar. 2026, which is 6% below its 10-year median of 204.83. GuruFocus rates FRA:TF2 with a GF Score™ of 71/100 and a GF Value™ of €4.46. The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Takara Bio ranks worse than 58.62% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Takara Bio's Average Total Inventories for the
three
months ended in Mar. 2026 was €66.9 Mil. Takara Bio's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €31.6 Mil.
Hence, Takara Bio's Days Inventory for the
three
months ended in Mar. 2026 was 192.94.
The historical rank and industry rank for Takara Bio's Days Inventory or its related term are showing as below:
FRA:TF2'
s Days Inventory Range Over the Past 10 Years
Min: 153.29 Med: 204.83 Max: 328.2
Current: 228.86
During the past 13 years, Takara Bio's highest Days Inventory was 328.20. The lowest was 153.29. And the median was 204.83.
FRA:TF2's Days Inventory is ranked worse than 58.62% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs FRA:TF2: 228.86
Takara Bio's Days Inventory
declined
from Mar. 2025 (202.86) to Mar. 2026 (192.94).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Takara Bio's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Takara Bio's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.03.
Takara Bio (FRA:TF2) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Takara Bio's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Takara Bio's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Takara Bio Days Inventory Related Terms
Takara Bio Days Inventory Historical Data
* Premium members only.
The historical data trend for Takara Bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:TF2 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Takara Bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takara Bio Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Takara Bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where Takara Bio's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takara Bio (FRA:TF2) has a Days Inventory of 192.94 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Takara Bio and its competitors. This is near median its historical median of 204.83. Over the past decade, Takara Bio's Days Inventory has ranged from 153.29 to 328.20. According to the industry distribution chart, Takara Bio ranks #374 out of 638 companies in the Biotechnology industry, placing it in the top 58.6%.
Is Takara Bio's Days Inventory too high?
Takara Bio's current Days Inventory of 192.94 is near median its 10-year median of 204.83. Over the past 10 years, this metric has ranged from a low of 153.29 to a high of 328.20. The Biotechnology industry median Days Inventory is 183.88. Takara Bio's value of 192.94 is 4.9% above this industry median. Based on the distribution chart, Takara Bio ranks #374 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Takara Bio has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Takara Bio's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Takara Bio ranks #374 out of 638 companies for Days Inventory. This places Takara Bio in the lower half of its industry. The industry median Days Inventory is 183.88. Takara Bio's value of 192.94 is 4.9% above this benchmark. Historically, Takara Bio's own Days Inventory has ranged from 153.29 to 328.20 over the past decade. While the company's 10-year median is 204.83 vs. the industry median of 183.88, Takara Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takara Bio's current Days Inventory of 192.94 is 4.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Takara Bio and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takara Bio's current Days Inventory is 192.94, which is near median its own 10-year median of 204.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takara Bio stock overvalued right now?
Takara Bio (FRA:TF2) has a current Days Inventory of 192.94. The stock's GF Value™ is €4.46, compared to a current price of €5.95 — trading 33.4% above its estimated fair value. The current Days Inventory is 192.94, which is near median its 10-year median of 204.83 and 4.9% above the Biotechnology industry median of 183.88. Takara Bio's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Takara Bio (FRA:TF2), the current Days Inventory is 192.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takara Bio (FRA:TF2) Overvalued in 2026?
Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued.
The current stock price of €5.95 is trading 33.4% above its estimated GF Value™ of €4.46.
Key valuation signals for FRA:TF2:
Days Inventory: 192.94 (near median its 10-year median of 204.83)
GF Value™: €4.46 vs. price of €5.95 (33.4% above fair value)
Industry Position: 4.9% above the Biotechnology median (#374 of 638)
No single metric tells the full story. See the FRA:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
71GF Score
Get the complete analysis for FRA:TF2
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TF2 has been successfully added to your 
